Genscript Biotech Announces Board Reshuffle

Genscript Biotech Announces Board Reshuffle

Genscript Biotech (HK:1548) has released an update.

Genscript Biotech Corporation has announced the resignation of two key members, Ms. Wang Jiafen and Dr. Wang Xuehai, effective from 5 July 2024, due to retirement and a desire to focus on other business commitments, respectively. The company has appointed Dr. Shi Chenyang as a new member of the Strategy Committee, maintaining a four-member composition. The board expressed appreciation for the contributions of the departing members and welcomed the new appointee.

For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App